Adaptin Bio (APTN) Retained Earnings (2022 - 2026)

Adaptin Bio (APTN) has 5 years of Retained Earnings data on file, last reported at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 283.22% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 283.22% YoY), and the FY2025 full-year result was -$9.3 million, down 39155.95% from the prior year.
• Retained Earnings climbed to $8.7 million in Q1 2026, from -$9.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $8.7 million in Q1 2026 to a low of -$9.3 million in Q4 2025.
• A 5-year average of -$1.7 million and a median of -$188369.0 in 2024 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings sank 39155.95% in 2025 and soared 283.22% in 2026, its largest moves.
• Tracing APTN's Retained Earnings over 5 years: stood at -$27804.0 in 2022, then slumped by 307.84% to -$113397.0 in 2023, then soared by 120.98% to $23791.0 in 2024, then slumped by 39155.95% to -$9.3 million in 2025, then jumped by 193.22% to $8.7 million in 2026.
• Business Quant data shows APTN's Retained Earnings at $8.7 million in Q1 2026, -$9.3 million in Q4 2025, and -$7.9 million in Q3 2025.